title: Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia.
authors.affiliation: Department of Haematology, Eastbourne District General Hospital, Eastbourne, UK. tom.rider@nhs.net.
authors.forename: Tom G
authors.initials: TG
authors.lastname: Rider
authors.affiliation: Department of Haematology, Eastbourne District General Hospital, Eastbourne, UK.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Grace
authors.affiliation: Department of Haematology, Eastbourne District General Hospital, Eastbourne, UK.
authors.forename: Joel A
authors.initials: JA
authors.lastname: Newman
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D011720:Pyrazoles; D011743:Pyrimidines
keywords: anaemia; autoimmune haemolytic anaemia; chronic lymphocytic leukaemia; ibrutinib